Sibutramine

Sibutramine

CAS Number:

106650-56-0

Batch Molecular Formula:

C17H26ClN

Batch Molecular Weight:

279.85 g/mol

Physical Appearance:

White to Off White Crystalline Powder

Solubility:

Soluble in Water

Storage:

Store at RT

Sibutramine hydrochloride (HCl) is a medication that was primarily used as an appetite suppressant for weight loss. It acts on the central nervous system to promote satiety, helping individuals consume fewer calories. Although it was effective for weight management, its use has been discontinued in many countries due to concerns about cardiovascular risks.

Original Sibutramine HCL Formulations
  • Brand Names: Meridia (U.S.), Reductil (Europe), Sibutrex, and others.

Delphis Pharma – Leading Sibutramine Manufacturer & Contract Manufacturer in India & Global Markets

Delphis Pharma is a trusted manufacturer and contract manufacturer of Sibutramine in India and international markets. We offer custom manufacturing solutions, competitive pricing, and seamless logistics tailored to your needs. Partner with us for high-quality Sibutramine production and global supply.

Contact our sales team today for personalized deals and efficient delivery solutions!

Effects

1. Positive Effects
  • Reduced appetite and caloric intake.

  • Modest weight loss when combined with lifestyle changes.

  • Improved metabolic markers in some individuals.

2. Negative Effects
  • Common Side Effects:

    • Dry mouth, headache, constipation, and insomnia.

    • Increased heart rate and blood pressure.

  • Severe Side Effects:

    • Cardiovascular risks, including heart attack and stroke.

    • Mood changes, anxiety, and potential for serotonin syndrome.

Usage

1. Primary Use
  • Obesity Management: Prescribed to aid in weight loss for individuals with a body mass index (BMI) ≥30 kg/m² or ≥27 kg/m² with obesity-related conditions (e.g., diabetes, hypertension).

  • Functioned as part of a comprehensive weight-loss plan, including diet and exercise.

2. Mechanism of Action:
  • Sibutramine inhibits the reuptake of serotonin, norepinephrine, and dopamine, increasing their levels in the brain. This enhances feelings of fullness and reduces appetite.

Disclaimer

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.

Disclaimer:

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.

Disclaimer:

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.

Disclaimer:

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.

Disclaimer:

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.